Renin-angiotensin system inhibitors and susceptibility to COVID-19 in patients with hypertension: a propensity score-matched cohort study in primary care.
Shamil HaroonAnuradhaa SubramanianJennifer CooperAstha AnandKrishna GokhaleNathan ByneSamir DhallaDionisio Acosta-MenaThomas TavernerKelvin OkothJingya WangJoht Singh ChandanChristopher SainsburyDawit Tefra ZemedikunG Neil ThomasDhruv ParekhTom MarshallElizabeth SapeyNicola Jaime AdderleyKrishnarajah NirantharakumarPublished in: BMC infectious diseases (2021)
Use of ACE inhibitors was not associated with the risk of COVID-19 whereas use of ARBs was associated with a statistically non-significant increase compared to the use of CCBs. However, no significant associations were observed between prescription of either ACE inhibitors or ARBs and all-cause mortality.